TLR4 and metabolic dysfunction-associated steatotic liver disease: Many studies showed the evidence for the pathogenic role of TLR4/LPS signaling in the progression of alcoholic and nonalcoholic fatty liver diseases [ALD, non-alcoholic fatty liver disease (NAFLD)] and hepatocellular carcinoma (3, 11, 12).